Story Poster
Photo by Bear Insider
Cal Basketball

The Rodcast: Top Six

October 28, 2024
2,231

In today's podcast, former Cal and professional center and Bear Insider commentator Rod Benson talks about Cal hoops predicted finish, promoting the Cal brand and more.

Click here to listen on Soundcloud, Spotify, Apple Podcasts or on many of your favorite podcast services.

Related:

The Rodcast: Meet the Bears

The Rodcast: We Beat The Brakes Off Auburn

 

Discussion from...

The Rodcast: Top Six

1,867 Views | 3 Replies | Last: 1 mo ago by Shocky1
BC Calfan
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
8:31a, 10/29/24
Like Rod's points about why we should be improved. The loss of Daws and addition of 2 big men that can move and defend will give us more versatility. He briefly mentions culture too and that he "heard some things" about Askew. This year's team seems to be filled with good teammates. Rod knows his hoops and he's expecting a top 6 finish!
Reply Quote
1
philbert
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
11:02a, 10/29/24
I am a little curious about Askew's effect on chemistry last year. He was out for a lot of the season with injury. Did he screw with locker room chemistry even while sitting out?
Reply Quote
Shocky1
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
11:42a, 10/29/24
philbert, rod is repeating shocky's report that askew smoked dope before a game last season in addition to just being a bad teammate (on a team with a lotta bad attitudes, the least likable team in the history of cal athletics) but to his credit devin did earn a berkeley degree before moving on to long beach state this season
Reply Quote
1
1 edit
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.